Adam D. Cutler

Insider Reports History

Entity
Individual
Location
9301 Amberglen Boulevard, Suite 100, C/O Molecular Templates, Inc., Austin, TX
Signature
/s/ Maiken Keson-Brookes, attorney-in-fact for Adam D. Cutler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam D. Cutler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mural Oncology plc Chief Financial Officer Ordinary Shares 106K $414K $3.89 Mar 3, 2025 Direct
Mural Oncology plc Chief Financial Officer Stock Option (right to buy) 65K $218K $3.35 Mar 3, 2025 Direct
InMed Pharmaceuticals Inc. Director Employee Stock Option (Right to Buy) 46.4K Dec 29, 2021 Direct
InMed Pharmaceuticals Inc. Director Employee Stock Option (Expiration) 16.1K Jan 24, 2022 Direct

Insider Reports Filed by Adam D. Cutler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MURA Mural Oncology plc Mar 3, 2025 2 $0 4 Mar 5, 2025 Chief Financial Officer
MURA Mural Oncology plc Oct 31, 2024 1 -$25.3K 4 Nov 1, 2024 Chief Financial Officer
MURA Mural Oncology plc Dec 14, 2023 2 $0 4 Dec 18, 2023 Chief Financial Officer
MURA Mural Oncology plc Nov 15, 2023 0 $0 3 Nov 15, 2023 Chief Financial Officer
INM InMed Pharmaceuticals Inc. Jan 24, 2022 3 $0 4 Jan 24, 2022 Director
INM InMed Pharmaceuticals Inc. Dec 29, 2021 1 $0 4 Dec 30, 2021 Director